Related Experiment Video
Updated: Mar 26, 2026
07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.7K
Predicting chemotherapeutic drug combinations through gene network profiling.
Thi Thuy Trang Nguyen1,2, Jacqueline Kia Kee Chua1,3, Kwi Shan Seah1,2
1Department of Biochemistry, National University of Singapore, Singapore.
Scientific Reports
|January 22, 2016
Summary
This study uses fission yeast to identify effective chemotherapy drug combinations. Combining doxorubicin with cisplatin and suberoylanilide hydroxamic acid shows promise for treating gastric cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Yeast Genetics
Background:
- Chemotherapy often uses drug combinations, but selecting optimal agents is challenging.
- Understanding drug resistance gene networks is crucial for effective combination therapy.
Purpose of the Study:
- To develop a targeted approach for selecting chemotherapeutic drug combinations.
- To identify synergistic drug combinations for cancer treatment using a model organism.
Main Methods:
- Utilized fission yeast (Schizosaccharomyces pombe) as a model for proliferating cells.
- Employed a synthetic lethality workflow to delineate drug resistance gene networks.
- Assessed genetic overlap between doxorubicin and six other drugs with varied mechanisms.
Main Results:
- Identified drug-specific ontological sub-classifications via relative hypersensitivity computations.
- Demonstrated that human gastric adenocarcinoma cells are sensitized to doxorubicin by cisplatin and suberoylanilide hydroxamic acid.
- Validated the utility of fission yeast in modeling conserved gene interaction networks.
Conclusions:
- Fission yeast serves as an effective model for screening chemotherapeutic drug combinations.
- Targeting conserved gene interaction networks can lead to successful drug combinations for human cancers.
- Concomitant treatment with cisplatin and suberoylanilide hydroxamic acid enhances doxorubicin efficacy.
More Related Videos
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
67
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
67
02:26Protein Networks
4.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K
01:29Pharmacogenomics: Identification of New Drug Targets
76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
01:27Pharmacogenetics of Drug Metabolism: Overview
108
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
108
01:26Drug Discovery: Overview
13.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.2K